ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,745, issued on May 13, was assigned to Ascensia Diabetes Care Holdings AG (Basel, Switzerland).
"Sterilized reusable wearable devices and wearable device forming methods in continuous analyte monitoring" was invented by Eugene Prais (West Milford, N.J.), Dragan Avirovikj (Stamford, Conn.), Thomas A. J. Mayer Jr. (Glenmoore, Pa.), Cameron M. Young (Tarrytown, N.Y.) and Igor Y. Gofman (Croton-on-Hudson, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "In one or more embodiments, a continuous analyte monitoring wearable device includes a disposable base unit having a power source and an analyte sensor, and a reusable transmitter unit that includes e...